Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial, intrathecal, and intravenous use. It enhances radiodensity during diagnostic imaging procedures such as angiography, myelography, and computed tomography.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres, and clinics worldwide.

Iomeron (iomeprol) is an iodinated contrast agent used in radiographic procedures to improve visualization of vascular and other anatomical structures. - Angiography: provides enhanced visualization of blood vessels for detailed vascular assessment. - Myelography: improves delineation of the spinal canal and nerve roots during spinal imaging. - Computed tomography (CT) imaging: increases contrast between tissues for clearer CT images.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warm sensation or flushing at the injection site. - Nausea or mild vomiting. - Taste alteration or metallic taste. - Mild headache. - Transient hypotension. - Injection site discomfort.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Profound hypotension or cardiovascular collapse. - Cardiac arrhythmias. - Pulmonary edema. - Seizures or neurological disturbances.

Before administering Iomeron, clinicians should observe several safety measures. - Assess renal function: evaluate eGFR or serum creatinine to identify patients at risk of contrast‑induced nephropathy. - Screen for iodine allergy: obtain a detailed history of prior contrast reactions. - Ensure adequate hydration: encourage fluid intake before and after the procedure to support renal clearance. - Use the lowest effective dose: limit volume to the minimum required for diagnostic quality. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Iomeron can interact with certain medications, influencing safety or efficacy.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in patients with renal impairment. - Thyroid hormone replacement: contrast may interfere with thyroid function tests. - High‑dose steroids: may increase the likelihood of contrast‑induced nephropathy.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate renal effects; monitor kidney function. - ACE inhibitors or ARBs: observe for changes in renal parameters. - NSAIDs: increase risk of kidney injury; consider temporary discontinuation.